Veenstra D

No ORCID on file · 1 paper in corpus · active 2019
2019
PharmacoEconomics ·doi:10.1007/s40273-019-00832-2

Transparency in decision modeling remains a topic of rigorous debate among healthcare stakeholders, given tensions between the potential benefits of external access during model development and the need to protect intellectual property and …